Hyperibone J exerts antidepressant effects by targeting ADK to inhibit microglial P2X7R/TLR4-mediated neuroinflammation

Introduction: The antidepressant properties of Hypericum species are known. Hyperibone J, a principal component found in the flowers of Hypericum bellum, exhibited in vitro anti-inflammatory effects. However, the antidepressant effects and mechanisms of Hyperibone J remain to be elucidated. Adenosin...

Full description

Saved in:
Bibliographic Details
Main Authors: Ting Li, Yawei Li, Jinhu Chen, Miaomiao Nan, Xin Zhou, Lifang Yang, Wenjun Xu, Chao Zhang, Lingyi Kong
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Journal of Advanced Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2090123224002984
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849328014542766080
author Ting Li
Yawei Li
Jinhu Chen
Miaomiao Nan
Xin Zhou
Lifang Yang
Wenjun Xu
Chao Zhang
Lingyi Kong
author_facet Ting Li
Yawei Li
Jinhu Chen
Miaomiao Nan
Xin Zhou
Lifang Yang
Wenjun Xu
Chao Zhang
Lingyi Kong
author_sort Ting Li
collection DOAJ
description Introduction: The antidepressant properties of Hypericum species are known. Hyperibone J, a principal component found in the flowers of Hypericum bellum, exhibited in vitro anti-inflammatory effects. However, the antidepressant effects and mechanisms of Hyperibone J remain to be elucidated. Adenosine kinase (ADK) is upregulated in epilepsy and depression and has been implicated in promoting neuroinflammation. Objectives: This study aimed to explore the impact of Hyperibone J on neuroinflammation-mediated depression and the mechanism underlying this impact. Methods: This study employed acute and chronic in vivo depression models and an in vitro LPS-induced depression model using BV-2 microglia. The in vivo antidepressant efficacy of Hyperibone J was assessed through behavioral assays. Techniques such as RNA-seq, western blot, qPCR and ELISA were utilized to elucidate the direct target and mechanism of action of Hyperibone J. Results: Compared with the model group, depression-like behaviors were significantly alleviated in the Hyperibone J group. Furthermore, Hyperibone J mitigated hippocampal neuroinflammation and neuronal damage. RNA-seq suggested that Hyperibone J predominantly influenced inflammation-related pathways. In vitro experiments revealed that Hyperibone J reversed the LPS-induced overexpression and release of inflammatory factors. Network pharmacology and various molecular biology experiments revealed that the potential binding of Hyperibone J at the ASN-312 site of ADK diminished the stability and protein expression of ADK. Mechanistic studies revealed that Hyperibone J attenuated the ADK/ATP/P2X7R/Caspase-1-mediated maturation and release of IL-1β. The study also revealed a significant correlation between Tlr4 expression and depression-like behaviors in mice. Hyperibone J downregulated ADK, inhibiting Tlr4 transcription, which in turn reduced the phosphorylation of NF-κB and the subsequent transcription of Nlrp3, Il-1b, Tnf, and Il-6. Conclusion: Hyperibone J exerted antineuroinflammatory and antidepressant effects by binding to ADK in microglia, reducing its expression and thereby inhibiting the ATP/P2X7R/Caspase-1 and TLR4/NF-κB pathways. This study provides experimental evidence for the therapeutic potential of Hypericum bellum.
format Article
id doaj-art-0b1080e1e8d84dbb8f3ead6a41a3e1ac
institution Kabale University
issn 2090-1232
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series Journal of Advanced Research
spelling doaj-art-0b1080e1e8d84dbb8f3ead6a41a3e1ac2025-08-20T03:47:41ZengElsevierJournal of Advanced Research2090-12322025-06-017257158910.1016/j.jare.2024.07.015Hyperibone J exerts antidepressant effects by targeting ADK to inhibit microglial P2X7R/TLR4-mediated neuroinflammationTing Li0Yawei Li1Jinhu Chen2Miaomiao Nan3Xin Zhou4Lifang Yang5Wenjun Xu6Chao Zhang7Lingyi Kong8Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Shenzhen Research Institute, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaJiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Shenzhen Research Institute, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaJiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Shenzhen Research Institute, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaJiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Shenzhen Research Institute, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaJiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Shenzhen Research Institute, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaSchool of Chemistry and Chemical Engineering, Guangxi University for Nationalities, Nanning 530008, ChinaJiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Shenzhen Research Institute, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China; Corresponding authors.Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Shenzhen Research Institute, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China; Corresponding authors.Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Shenzhen Research Institute, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China; Corresponding authors.Introduction: The antidepressant properties of Hypericum species are known. Hyperibone J, a principal component found in the flowers of Hypericum bellum, exhibited in vitro anti-inflammatory effects. However, the antidepressant effects and mechanisms of Hyperibone J remain to be elucidated. Adenosine kinase (ADK) is upregulated in epilepsy and depression and has been implicated in promoting neuroinflammation. Objectives: This study aimed to explore the impact of Hyperibone J on neuroinflammation-mediated depression and the mechanism underlying this impact. Methods: This study employed acute and chronic in vivo depression models and an in vitro LPS-induced depression model using BV-2 microglia. The in vivo antidepressant efficacy of Hyperibone J was assessed through behavioral assays. Techniques such as RNA-seq, western blot, qPCR and ELISA were utilized to elucidate the direct target and mechanism of action of Hyperibone J. Results: Compared with the model group, depression-like behaviors were significantly alleviated in the Hyperibone J group. Furthermore, Hyperibone J mitigated hippocampal neuroinflammation and neuronal damage. RNA-seq suggested that Hyperibone J predominantly influenced inflammation-related pathways. In vitro experiments revealed that Hyperibone J reversed the LPS-induced overexpression and release of inflammatory factors. Network pharmacology and various molecular biology experiments revealed that the potential binding of Hyperibone J at the ASN-312 site of ADK diminished the stability and protein expression of ADK. Mechanistic studies revealed that Hyperibone J attenuated the ADK/ATP/P2X7R/Caspase-1-mediated maturation and release of IL-1β. The study also revealed a significant correlation between Tlr4 expression and depression-like behaviors in mice. Hyperibone J downregulated ADK, inhibiting Tlr4 transcription, which in turn reduced the phosphorylation of NF-κB and the subsequent transcription of Nlrp3, Il-1b, Tnf, and Il-6. Conclusion: Hyperibone J exerted antineuroinflammatory and antidepressant effects by binding to ADK in microglia, reducing its expression and thereby inhibiting the ATP/P2X7R/Caspase-1 and TLR4/NF-κB pathways. This study provides experimental evidence for the therapeutic potential of Hypericum bellum.http://www.sciencedirect.com/science/article/pii/S2090123224002984DepressionNeuroinflammationADKTLR4P2X7RNF-κB
spellingShingle Ting Li
Yawei Li
Jinhu Chen
Miaomiao Nan
Xin Zhou
Lifang Yang
Wenjun Xu
Chao Zhang
Lingyi Kong
Hyperibone J exerts antidepressant effects by targeting ADK to inhibit microglial P2X7R/TLR4-mediated neuroinflammation
Journal of Advanced Research
Depression
Neuroinflammation
ADK
TLR4
P2X7R
NF-κB
title Hyperibone J exerts antidepressant effects by targeting ADK to inhibit microglial P2X7R/TLR4-mediated neuroinflammation
title_full Hyperibone J exerts antidepressant effects by targeting ADK to inhibit microglial P2X7R/TLR4-mediated neuroinflammation
title_fullStr Hyperibone J exerts antidepressant effects by targeting ADK to inhibit microglial P2X7R/TLR4-mediated neuroinflammation
title_full_unstemmed Hyperibone J exerts antidepressant effects by targeting ADK to inhibit microglial P2X7R/TLR4-mediated neuroinflammation
title_short Hyperibone J exerts antidepressant effects by targeting ADK to inhibit microglial P2X7R/TLR4-mediated neuroinflammation
title_sort hyperibone j exerts antidepressant effects by targeting adk to inhibit microglial p2x7r tlr4 mediated neuroinflammation
topic Depression
Neuroinflammation
ADK
TLR4
P2X7R
NF-κB
url http://www.sciencedirect.com/science/article/pii/S2090123224002984
work_keys_str_mv AT tingli hyperibonejexertsantidepressanteffectsbytargetingadktoinhibitmicroglialp2x7rtlr4mediatedneuroinflammation
AT yaweili hyperibonejexertsantidepressanteffectsbytargetingadktoinhibitmicroglialp2x7rtlr4mediatedneuroinflammation
AT jinhuchen hyperibonejexertsantidepressanteffectsbytargetingadktoinhibitmicroglialp2x7rtlr4mediatedneuroinflammation
AT miaomiaonan hyperibonejexertsantidepressanteffectsbytargetingadktoinhibitmicroglialp2x7rtlr4mediatedneuroinflammation
AT xinzhou hyperibonejexertsantidepressanteffectsbytargetingadktoinhibitmicroglialp2x7rtlr4mediatedneuroinflammation
AT lifangyang hyperibonejexertsantidepressanteffectsbytargetingadktoinhibitmicroglialp2x7rtlr4mediatedneuroinflammation
AT wenjunxu hyperibonejexertsantidepressanteffectsbytargetingadktoinhibitmicroglialp2x7rtlr4mediatedneuroinflammation
AT chaozhang hyperibonejexertsantidepressanteffectsbytargetingadktoinhibitmicroglialp2x7rtlr4mediatedneuroinflammation
AT lingyikong hyperibonejexertsantidepressanteffectsbytargetingadktoinhibitmicroglialp2x7rtlr4mediatedneuroinflammation